[1] Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies[J]. Exp Neurol, 2021, 335:113518.
[2] Li M, Tang H, Li Z, et al. Emerging treatment strategies for cerebral ischemia-reperfusion injury[J]. Neuroscience, 2022, 507:112-124.
[3] Duan WL, Wang XJ, Ma YP, et al. Therapeutic strategies targeting the NLRP3-mediated inflammatory response and pyroptosis in cerebral ischemia/reperfusion injury (Review)[J]. Mol Med Rep, 2024, 29(3):46.
[4] Xu R, Peng Q, Chen W, et al. ncRNAs-mediated pyroptosis in cerebral ischemia-reperfusion injury: pathophysiology, mechanisms, and therapeutic perspectives[J]. Curr Issues Mol Biol, 2025, 47(3):141.
[5] Qian L, Li M, Lin X, et al. Interleukin-35 attenuates blood-brain barrier dysfunction caused by cerebral ischemia-reperfusion injury through inhibiting brain endothelial cell injury[J]. Ann Transl Med, 2022, 10(14):776.
[6] Li R, Jia H, Si M, et al. Loureirin B protects against cerebral ischemia/reperfusion injury through modulating M1/M2 microglial polarization via STAT6 / NF-kappaB signaling pathway[J]. Eur J Pharmacol, 2023, 953:175860.
[7] Long HL, Tao XR, Feng XL, et al. The protective effect and mechanism of Danji Granules on rats with cerebral ischemia-reperfusion injury [J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2025, 36(4): 499-505. (in Chinese)
龙慧玲, 陶新如, 冯小龙, 等. 丹膝颗粒对脑缺血再灌注损伤大鼠的保护作用及机制[J]. 中药新药与临床药理, 2025, 36(4):499-505.
[8] Chen S, Ma MJ, Wang LN, et al. Regulation of acid-sensitive ion channels by total flavonoids of tripterygium wilfordii and its analgesic effect [J]. Journal of South-Central University for Nationalities (Natural Science Edition), 2021, 40(2): 158-164. (in Chinese)
陈素, 马敏洁, 王丽娜, 等. 龙血竭总黄酮对酸敏感离子通道的调控及其镇痛作用[J]. 中南民族大学学报(自然科学版), 2021, 40(2):158-164.
[9] Wang F, Mei QCh, Feng J, et al. The effect of sakuranetin on the improvement of oxidative and inflammatory damage in chondrocytes of knee osteoarthritis rats through regulating the ROS/TXNIP pathway [J]. Chinese Journal of Gerontology, 2024, 44(1): 229-233. (in Chinese)
王飞, 梅群超, 冯晶, 等. 山奈酚调控ROS/TXNIP通路对膝骨关节炎大鼠软骨细胞氧化及炎性损伤的改善作用[J]. 中国老年学杂志, 2024, 44(1):229-233.
[10] Li Y, Tan L, Yang C, et al. Distinctions between the Koizumi and Zea Longa methods for middle cerebral artery occlusion (MCAO) model: a systematic review and meta-analysis of rodent data[J]. Sci Rep, 2023, 13(1):10247.
[11] Duan M, Yu N, Liu J, et al. Remimazolam suppresses oxidative stress and apoptosis in cerebral ischemia/reperfusion injury by regulating AKT/GSK-3β/NRF2 pathway[J]. Drug Des Devel Ther, 2025, 19:111-128.
[12] Gao N, Huang Z, Xie J, et al. Cryptotanshinone alleviates cerebral ischemia reperfusion injury by regulating ferroptosis through the PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway[J]. J Ethnopharmacol, 2025, 348:119800.
[13] Xie M, Zhong Zh, Ouyang XY, et al. The effect of ligustrazine on the inflammatory response and cell apoptosis after cerebral ischemia/reperfusion injury in rats [J]. Acta Anatomica Sinica, 2021, 52(6): 845-854. (in Chinese)
谢明, 钟朕, 欧阳训彦, 等. 川芎嗪防治大鼠脑缺血/再灌注损伤后炎症反应与细胞凋亡的作用[J]. 解剖学报, 2021, 52(6):845-854.
[14] Zheng Y, Xu X, Chi F, et al. Pyroptosis: a newly discovered therapeutic target for ischemia-reperfusion injury[J]. Biomolecules, 2022,12(11):1625.
[15] Ge Q, Chen X, Zhao Y, et al. Modulatory mechanisms of NLRP3: potential roles in inflammasome activation[J]. Life Sci, 2021, 267:118918.
[16] Liang Y, Song P, Chen W, et al. Inhibition of Caspase-1 ameliorates ischemia-associated blood-brain barrier dysfunction and integrity by suppressing pyroptosis activation[J]. Front Cell Neurosci, 2021, 14:540669.
[17] Chen S, Hao P, Liang Y, et al. Electroacupuncture protects against cerebral ischemia-reperfusion injury: reducing inflammatory response and cell pyroptosis by inhibiting P2X7/NLRP3/GSDMD pathway[J]. Neuropsychiatr Dis Treat, 2024, 20:2335-2346.
[18] Zhang Y, Yao Z, Xiao Y, et al. Downregulated XBP-1 rescues cerebral ischemia/reperfusion injury-induced pyroptosis via the NLRP3/Caspase-1/GSDMD axis[J]. Mediators Inflamm, 2022, 2022:8007078.
[19] Chen PQ, Ban WK, Wang WY, et al. Research progress on the pharmacological effects and mechanisms of dragon’s blood bark and its main active components on cerebral ischemia [J]. Chinese Herbal Medicine, 2023, 54(18): 6172-6184. (in Chinese)
陈品秋, 班玮康, 王文艳, 等. 龙血竭及其主要活性成分对脑缺血的药理作用与机制研究进展[J]. 中草药, 2023, 54(18):6172-6184.
[20] Zhang XY, Cai YY, Wang YY, et al. The brain-protective effect of Laohuji (a traditional Thai medicine) on rats with cerebral ischemia [J]. Grain and Oil Food Technology, 2022, 30(3): 148-155. (in Chinese)
张晓燕, 蔡宇宇, 王玉瑶, 等. 傣药龙血竭对脑缺血大鼠的脑保护作用[J]. 粮油食品科技,2022,30(3):148-155.
[21] Liu Y, Mi Y, Wang Y, et al. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice[J]. Phytomedicine, 2023, 113:154729.
[22] Xu J, Liu J, Li Q, et al. Loureirin C ameliorates ischemia and reperfusion injury in rats by inhibiting the activation of the TLR4/NF-κB pathway and promoting TLR4 degradation[J]. Phytother Res, 2022, 36(12):4527-4541.
[23] Zhu L, Yang YM, Huang Y, et al. Shexiang Tongxin dropping pills protect against ischemic stroke-induced cerebral microvascular dysfunction via suppressing TXNIP/NLRP3 signaling pathway[J]. J Ethnopharmacol, 2024, 322:117567.
[24] Long YZh, Liu H, Zhang YX, et al. Research on the extension of the thrombolytic time window for acute ischemic stroke by idarucizumab pre-adaptation and exploration of the mechanism involving the ROS/TXNIP/NLRP3 pathway [J]. Chinese Journal of Brain Diseases and Rehabilitation (Electronic Edition), 2023, 13(2): 65-74. (in Chinese)
隆昱洲, 柳华, 张云茜, 等. 依达拉奉预适应延长急性缺血性脑卒中溶栓时间窗的研究及ROS/TXNIP/NLRP3通路参与机制的探讨[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(2):65-74.
[25] Tan Z, Dong F, Wu L, et al. Transcutaneous electrical nerve stimulation (TENS) alleviates brain ischemic injury by regulating neuronal oxidative stress, pyroptosis, and mitophagy[J]. Mediators Inflamm, 2023, 2023:5677865.
[26] Shang S, Sun F, Zhu Y, et al. Sevoflurane preconditioning improves neuroinflammation in cerebral ischemia/reperfusion induced rats through ROS-NLRP3 pathway[J]. Neurosci Lett, 2023, 801:137164.
[27] Chen Y, Li H, Yang Y, et al. Polygalasaponin F ameliorates middle cerebral artery occlusion-induced focal ischemia/reperfusion injury in rats through inhibiting TXNIP/NLRP3 signaling pathway[J]. J Neuroimmunol, 2024, 387:578281.